Adaptimmune Therapeutics Plc Ret. on equity
What is the Ret. on equity of Adaptimmune Therapeutics Plc?
The Ret. on equity of Adaptimmune Therapeutics Plc is -116.80%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Adaptimmune Therapeutics Plc
What does Adaptimmune Therapeutics Plc do?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Companies with ret. on equity similar to Adaptimmune Therapeutics Plc
- Kidsland International has Ret. on equity of -117.19%
- Property Solutions Acquisition has Ret. on equity of -117.18%
- Angus Ventures has Ret. on equity of -117.15%
- Global Oil & Gas has Ret. on equity of -117.06%
- Alvo Minerals Ltd has Ret. on equity of -117.05%
- GlycoMimetics Inc has Ret. on equity of -116.81%
- Adaptimmune Therapeutics Plc has Ret. on equity of -116.80%
- Achieve Life Sciences has Ret. on equity of -116.78%
- Exro Technologies has Ret. on equity of -116.74%
- Exro Technologies has Ret. on equity of -116.74%
- Exro Technologies Inc has Ret. on equity of -116.74%
- Nikola has Ret. on equity of -116.43%
- Eternity Technology has Ret. on equity of -116.39%